(Q37468880)

20 August 2017

1 reference

title

Neurochemical biomarkers in the differential diagnosis of movement disorders. (English)

1 reference

20 August 2017

0 references

0 references

2

Claudia Trenkwalder

1 reference

20 August 2017

1

Brit Mollenhauer

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

24

1 reference

20 August 2017

issue

10

1 reference

20 August 2017

page(s)

1411-1426

1 reference

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration

20 August 2017

cites work

1 reference

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

21 January 2018

1 reference

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease

21 January 2018

1 reference

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies

21 January 2018

1 reference

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

21 January 2018

1 reference

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

21 January 2018

1 reference

Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.

21 January 2018

1 reference

The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.

21 January 2018

1 reference

Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings

21 January 2018

1 reference

CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease

21 January 2018

1 reference

Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group.

21 January 2018

1 reference

CSF acetylcholinesterase levels are reduced in multiple system atrophy with autonomic failure.

21 January 2018

1 reference

Cerebrospinal fluid amyloid beta42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

CSF somatostatin-like immunoreactivity in dementia

21 January 2018

1 reference

beta-Endorphin cerebrospinal fluid decrease in untreated parkinsonian patients

21 January 2018

1 reference

Substance P in human cerebrospinal fluid: Reductions in peripheral neuropathy and autonomic dysfunction

21 January 2018

1 reference

CSF detection of the 14-3-3 protein in unselected patients with dementia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.22510

1 reference

20 August 2017

1 reference